Alligator Bioscience announces positive safety data from ATOR-1017 study
The research involves patients with advanced solid malignancies on tumour-directed therapy
Read More
Author: John Pinching
Positive in vitro results for Imutex’s FLU-v
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine
Read More
Regulatory approval received for Evgen’s SFX-01 study
New formulation may be suitable for large-scale trials and commercial supply in the future
Read More
MHRA appoints DEKRA to certify medical devices
DEKRA has become the first organisation to complete the new designation process
Read More
Shionogi reaches primary endpoint for ensitrelvir
Positive results in COVID-19 therapy phase 3 trials show effectiveness against five symptoms
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
